ams-OSRAM (OTCMKTS:AMSSY) Shares Gap Up – Time to Buy?

by · The Cerbat Gem

ams-OSRAM AG Unsponsored ADR (OTCMKTS:AMSSY – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $11.7216, but opened at $13.18. ams-OSRAM shares last traded at $12.54, with a volume of 214 shares changing hands.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of ams-OSRAM in a research report on Tuesday, May 12th. Jefferies Financial Group upgraded ams-OSRAM from a “hold” rating to a “buy” rating in a research report on Sunday, May 10th. Finally, Zacks Research upgraded ams-OSRAM from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Check Out Our Latest Analysis on ams-OSRAM

ams-OSRAM Stock Up 2.4%

The company has a current ratio of 1.47, a quick ratio of 1.11 and a debt-to-equity ratio of 2.64. The stock has a 50 day simple moving average of $7.07 and a 200 day simple moving average of $5.90. The firm has a market capitalization of $2.40 billion, a PE ratio of -10.08 and a beta of 1.52.

ams-OSRAM Company Profile

(Get Free Report)

ams-OSRAM AG is a global technology company specializing in optical solutions, combining the sensor expertise of ams with the lighting heritage of OSRAM. The company develops and manufactures a broad range of high-performance products, including light-emitting diodes (LEDs), laser diode and infrared (IR) emitters, optical sensors, and sensor interfaces. These components are used across a variety of applications to enable advanced illumination, sensing, and imaging capabilities.

The company’s product portfolio serves diverse end markets such as consumer electronics, automotive, industrial, and medical.

Further Reading